{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:42:52Z","timestamp":1776087772712,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.dsx.2019.01.050","type":"journal-article","created":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T10:50:12Z","timestamp":1549104612000},"page":"1309-1315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Serum chemerin levels in Polycystic Ovary Syndrome after metformin therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Ashraf A.","family":"Foda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Engy A.","family":"Foda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"El-Negeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab H.","family":"El-Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2019.01.050_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/ENDO:30:1:13","article-title":"Insulin resistance in PCOS","volume":"30","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.dsx.2019.01.050_bib2","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2019.01.050_bib3","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2337\/db08-1528","article-title":"Insulin and metformin regulate circulating and adipose tissue chemerin","volume":"58","author":"Tan","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.01.050_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000341840","article-title":"Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome","volume":"40","author":"Carmina","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.dsx.2019.01.050_bib5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/en.2009-1098","article-title":"Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes","volume":"151","author":"Ernst","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2019.01.050_bib6","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.bbrc.2009.12.150","article-title":"Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis","volume":"391","author":"Kaur","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dsx.2019.01.050_bib7","doi-asserted-by":"crossref","first-page":"23982","DOI":"10.1074\/jbc.M111.220491","article-title":"Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPAR gamma) target gene, promotes mesenchymal stem cell adipogenesis","volume":"286","author":"Muruganandan","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dsx.2019.01.050_bib8","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1210\/en.2007-0175","article-title":"Chemerin is a novel adipokine associated with obesity and metabolic syndrome","volume":"148","author":"Bozaoglu","year":"2007","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.dsx.2019.01.050_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double-blind placebo controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.dsx.2019.01.050_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0015-0282(02)04800-8","article-title":"Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome","volume":"79","author":"Hass","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.dsx.2019.01.050_bib11","first-page":"41","article-title":"Rotterdam 2004 Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2003","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.dsx.2019.01.050_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma and insulin concentration in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2019.01.050_bib13","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1111\/1471-0528.14764","article-title":"Metformin therapy for the management of infertility in women with polycystic ovary syndrome. Scientific impact paper No. 13","volume":"124","author":"Morley","year":"2017","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.dsx.2019.01.050_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/09513590.2011.650747","article-title":"Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI","volume":"28","author":"Akbarzadeh","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.dsx.2019.01.050_bib15","first-page":"535","article-title":"Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome","volume":"66","author":"Ademoglu","year":"2014","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.dsx.2019.01.050_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/09513590.2014.888412","article-title":"Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome","volume":"30","author":"Guzel","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.dsx.2019.01.050_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/09513590.2014.968547","article-title":"Chemerin as a marker of body fat and insulin resistance in woman with polycystic ovary syndrome","volume":"31","author":"Kort","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.dsx.2019.01.050_bib18","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1210\/en.2012-1424","article-title":"Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome","volume":"153","author":"Wang","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2019.01.050_bib19","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1210\/jc.2010-0042","article-title":"Chemerin, a novel adipokine in the regulation of angiogenesis","volume":"95","author":"Bozaoglu","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.dsx.2019.01.050_bib20","first-page":"796","article-title":"Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome","volume":"44","author":"Guvenc","year":"2016","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.dsx.2019.01.050_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3109\/09513590.2014.928687","article-title":"Elevated serum chemerin in Chinese women with hyperandrogenic PCOS","volume":"30","author":"Wang","year":"2014","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.050_bib22","first-page":"320","article-title":"Serum chemerin and polycystic ovarian syndrome","volume":"70","author":"Sepideh","year":"2012","journal-title":"Tehran Univ Med J"},{"key":"10.1016\/j.dsx.2019.01.050_bib23","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1210\/jc.2008-1833","article-title":"Chemerin is associated with metabolic syndrome phenotypes in a Mexican American population","volume":"94","author":"Bozaoglu","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.dsx.2019.01.050_bib24","doi-asserted-by":"crossref","first-page":"E514","DOI":"10.1210\/jc.2012-3673","article-title":"Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome","volume":"98","author":"Jialal","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402119300153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402119300153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T19:24:12Z","timestamp":1556738652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402119300153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1871402119300153"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2019.01.050","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum chemerin levels in Polycystic Ovary Syndrome after metformin therapy","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2019.01.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of Diabetes India.","name":"copyright","label":"Copyright"}]}}